MLTX · MoonLake Immunotherapeutics · Webcasts, Transcripts & Audio
Market Cap
$878.30M
Shares
85.11M
Volume · Oct 21
225.77K
Avg daily vol (3M)
1.51M
MoonLake Immunotherapeutics Webcasts
Earnings calls, investor updates, investor days and conferences for MoonLake Immunotherapeutics (MLTX), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.
Pull transcripts and briefs through the earnings call transcript API or MCP →
Add these events to your calendar (.ics)
Conference
Investor event
2026-12-03
MoonLake Immunotherapeutics (MLTX) December 3, 2026 Conference
Scheduled
No reported result — non-financial event
Audio
Transcript
Slides
Conference
Investor event
2026-12-03
MoonLake Immunotherapeutics (MLTX) December 3, 2026 Conference
Scheduled
No reported result — non-financial event
Audio
Transcript
Slides
Conference
Investor event
2026-11-11
MoonLake Immunotherapeutics (MLTX) November 11, 2026 Conference
Scheduled
No reported result — non-financial event
Audio
Transcript
Slides
Conference
Investor event
2026-11-10
MoonLake Immunotherapeutics (MLTX) November 10, 2026 Conference
Scheduled
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY25 · Q4
2026-02-23
MoonLake Immunotherapeutics (MLTX) Q4 2025 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q2
2024-08-07
MoonLake Immunotherapeutics (MLTX) Q2 2024 Earnings Call
Diluted EPS
$-0.39
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2024-02-29
MoonLake Immunotherapeutics (MLTX) Q4 2023 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q2
2023-08-10
MoonLake Immunotherapeutics (MLTX) Q2 2023 Earnings Call
Diluted EPS
$-0.23
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2023-03-20
MoonLake Immunotherapeutics (MLTX) Q4 2022 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Showing 1–9 of 9 webcasts
Key facts
CIK
1821586
CUSIP
61559X104
13F (30d)
11 filings
11 filers
Visit website
Investor relations